Commission Implementing Regulation (EU) 2017/1506 of 28 August 2017 renewing the approval of the active substance maleic hydrazide in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2017/1506
• Articles: 5

Article 1 Renewal of the approval of the active substance

The approval of the active substance maleic hydrazide is renewed as set out in Annex I.

Article 2 Amendments to Implementing Regulation (EU) No 540/2011

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Article 3 Entry into force and date of application

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 1 November 2017 except for the provision concerning hydrazine content specified in column ‘Purity’ of the table in Annex I, which shall apply from 1 November 2018.

Schedules & Appendices

ANNEX I

ANNEX I

Common Name,

Identification Numbers

IUPAC Name

Purity  ( 1 )

Date of approval

Expiration of approval

Specific provisions

Maleic hydrazide

CAS No 123-33-1

CIPAC No 310

6-hydroxy-2H-pyridazin-3-one

≥ 979 g/kg

Until 1 November 2018, the impurity hydrazine shall not exceed 1 mg/kg in the technical material.

From 1 November 2018, the impurity hydrazine shall not exceed 0,028 mg/kg in the technical material.

1 November 2017

31 October 2032

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on maleic hydrazide, and in particular Appendices I and II thereto, shall be taken into account.

In this overall assessment Member States shall pay particular attention to:

—

the protection of consumers,

—

the operator and worker safety; the conditions of the use should include the application of adequate personal protective equipment.

Member States shall ensure, where appropriate, that the label of the treated crops includes the indication that the crops were treated with maleic hydrazide, and the accompanying instructions to avoid exposure of the livestock.

Conditions of use shall include risk mitigation measures, where appropriate.

( 1 )   Further details on identity and specification of active substance are provided in the review report.

ANNEX II

ANNEX II

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in Part A, entry 52 on maleic hydrazide is deleted;

(2)

in Part B, the following entry is added:

Number

Common Name,

Identification Numbers

IUPAC Name

Purity  ( 1 )

Date of approval

Expiration of approval

Specific provisions

‘117

Maleic hydrazide

CAS No 123-33-1

CIPAC No 310

6-hydroxy-2H-pyridazin-3-one

≥ 979 g/kg

Until 1 November 2018, the impurity hydrazine shall not exceed 1 mg/kg in the technical material.

From 1 November 2018, the impurity hydrazine shall not exceed 0,028 mg/kg in the technical material.

1 November 2017

31 October 2032

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on maleic hydrazide, and in particular Appendices I and II thereto, shall be taken into account.

In this overall assessment Member States shall pay particular attention to:

—

the protection of consumers,

—

the operator and worker safety; the conditions of the use should include the application of adequate personal protective equipment.

Member States shall ensure, where appropriate, that the label of the treated crops includes the indication that the crops were treated with maleic hydrazide, and the accompanying instructions to avoid exposure of the livestock.

Conditions of use shall include risk mitigation measures, where appropriate.’

( 1 )   Further details on identity and specification of active substance are provided in the review report.